Tulavi Therapeutics has been awarded a national group purchasing agreement and Breakthrough Technology Designation for Synthetic Implantable Products with Premier, Inc. Effective September 15, 2026, ...

OpenAI is disrupting mathematics, alright. OpenAI is disrupting mathematics, alright. is a London-based reporter at The Verge covering all things AI and a Senior Tarbell Fellow. Previously, he wrote ...

Read about how mathematicians are dealing with the AI takeover of their field in our newest feature here. For the second time ever, someone has solved one of the seven Millennium Prize Problems—math’s ...

OpenAI announced on Sept. 8 that researchers using an unreleased internal model had solved a historic math problem. But the claimed breakthrough comes amid allegations from two mathematicians who say ...

Underground experiment being carried out in South Dakota It involves liquid xenon interacting with particles It could be 'first hint of a dark matter observation' Scientists stop short of claiming ...

For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For patients who were diagnosed with metastatic pancreatic cancer between 2015 and 2021, about 97% died within ...

The U.S. Food and Drug Administration just approved a new breakthrough drug for pancreatic cancer that significantly extends the lives of people with the disease—considered one of the most intractable ...

MRK and MRNA's intismeran autogene beat Keytruda alone on recurrence-free survival in Phase 3 melanoma, though no specific efficacy numbers have been released yet. BNTX surged 21% on read-across ...

Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at bay opens a new avenue of treatment that doctors hope will work against many types of tumors. Unlike ...

CHICAGO, Aug 19 (Reuters) - Merck (MRK.N), opens new tab and Moderna's (MRNA.O), opens new tab success with a personalized cancer vaccine designed to keep melanoma at bay opens a new avenue of ...

Stock prices for the American vaccine manufacturer Moderna more than doubled on Wednesday after the company reported successful results from its messenger RNA melanoma cancer vaccine. The mRNA shot, ...